Zeiss CIRRUS PathFinder Gains CE Mark for AI-Based OCT Analysis

Zeiss Medical Technology has obtained CE mark approval for its CIRRUS PathFinder, an AI-powered clinical support solution designed to interpret optical coherence tomography (OCT) scans. The tool employs advanced deep learning models to automatically detect abnormal macular OCT B-scans, helping clinicians prioritize areas requiring closer review and improve decision-making efficiency.

Seamlessly integrated into the CIRRUS system, PathFinder supports rapid image acquisition with high-definition clarity and a broad field of view. Its in-platform functionality removes the need for external analysis, enabling real-time assessment of multiple scans and streamlining clinical workflows.

The latest CIRRUS software release introduces additional features, including AI-enhanced OCT angiography (OCTA) visualisation, multi-layer segmentation for greater diagnostic precision, expanded reference databases, and strengthened cybersecurity and connectivity measures.

Currently available in select markets through licensing, this update complements Zeiss’s broader imaging portfolio. Recently, China’s NMPA also cleared the ZEISS CLARUS 700 retinal imaging system with fluorescein angiography.

08-09-2025